Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy: Technical Advances & Quantification

Post SIRT Y-90 time of flight (TOF) PET-MR: Initial experience

Michael Wissmeyer, Franz Buchegger, Habib Zaidi, Susanne Heinzer, Valentina Garibotto, Magalie Viallon, Christoph Becker, Osman Ratib and Sylvain Terraz
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 91;
Michael Wissmeyer
1Nuclear Medicine, University Hospital of Geneva (HUG), Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franz Buchegger
1Nuclear Medicine, University Hospital of Geneva (HUG), Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Habib Zaidi
1Nuclear Medicine, University Hospital of Geneva (HUG), Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susanne Heinzer
3Philips Healthcare, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentina Garibotto
1Nuclear Medicine, University Hospital of Geneva (HUG), Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magalie Viallon
2Radiology, University Hospital of Geneva (HUG), Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Becker
2Radiology, University Hospital of Geneva (HUG), Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osman Ratib
1Nuclear Medicine, University Hospital of Geneva (HUG), Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvain Terraz
2Radiology, University Hospital of Geneva (HUG), Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

91

Objectives To evaluate post interventional TOF PET-MR in patients undergoing SIRT using Y-90 labeled glass spheres.

Methods Since the beginning of our SIRT activity in early december 2010, we enrolled the first 3 consecutive patients scheduled for SIRT due to hepatocellular carcinoma (HCC) or liver metastases from other tumors into this pilot study. The therapeutic activities were calculated using volumetric CT or MRI and the hepatopulmonary shunt volume as assessed by a pre-therapy Tc-99m-MAA scintigraphy. After intraarterial application of the Y-90 labelled spheres, all patients underwent Brehmsstrahlung-SPECT-CT, followed by hybrid TOF PET-MR on a wole body PET-MR prototype (1 PET bed position centered on the liver followed by a T1 eTHRIVE and a T2 HASTE sequence). Image quality of Y-90 SPECT-CT and PET-MR were assessed using visual scores for lesion detectability and lesion to background contrast compared to pre-interventional exams.

Results The range of injected Y-90 activity was 1.7 to 5 GBq. No immediate or short term side-effects occurred. Post therapeutic SPECT-CT and PET-MR were feasible in all patients with a time consumption of 30 minutes for low dose SPECT-CT and 40 minutes for PET-MR. All previously detected tumor manifestations were visualized by both methods. However, PET-MR showed better lesion discrimination in multifocal disease, higher lesion/background (PET) and better soft tissue (MR) contrasts than SPECT-CT. Additionally, PET-MR provided a quantitative assessment by calculation of standardized uptake values.

Conclusions Y-90-TOF PET-MR proved to be feasible in all patients of this pilot cohort. It was superior to Bremsstrahlung-SPECT-CT in terms of lesion discrimination, lesion/background contrast and quantitative assessment. Given a high frequency of recruitment, more data will be available shortly. PET/MR might be an interesting alternative to post-therapy SPECT-CT, especially in the perspective of future dosimetric studies

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Post SIRT Y-90 time of flight (TOF) PET-MR: Initial experience
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Post SIRT Y-90 time of flight (TOF) PET-MR: Initial experience
Michael Wissmeyer, Franz Buchegger, Habib Zaidi, Susanne Heinzer, Valentina Garibotto, Magalie Viallon, Christoph Becker, Osman Ratib, Sylvain Terraz
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 91;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Post SIRT Y-90 time of flight (TOF) PET-MR: Initial experience
Michael Wissmeyer, Franz Buchegger, Habib Zaidi, Susanne Heinzer, Valentina Garibotto, Magalie Viallon, Christoph Becker, Osman Ratib, Sylvain Terraz
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 91;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy: Technical Advances & Quantification

  • Efficacy of partial volume-corrected FDG PET/CT in axillary nodal staging of breast cancer patients
  • Pharmacokinetic modeling of [18F]-ES tumor uptake in patients with breast cancer
  • Prognostic value of metabolic tumor volume of 18F-FDG PET/CT in advanced NSCLC
Show more Oncology: Basic, Translational & Therapy: Technical Advances & Quantification

Technical Advances & Quantification I: Radioembolization, Sentinel Nodes

  • Accuracy of pulmonary shunt measurements prior to 90Y selective internal radiotherapy: A phantom study
  • Investigating added value of freehand SPECT in sentinel node biopsy of melanomas
  • Imaging of Y90 distribution with PET/CT and bremsstrahlung SPECT/CT after radioembolization: A patient based study
Show more Technical Advances & Quantification I: Radioembolization, Sentinel Nodes

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire